TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
111.55
-3.41 (-2.97%)
At close: Sep 2, 2025, 4:00 PM
112.00
+0.45 (0.40%)
After-hours: Sep 2, 2025, 7:46 PM EDT
TransMedics Group Employees
TransMedics Group had 728 employees as of December 31, 2024. The number of employees increased by 144 or 24.66% compared to the previous year.
Employees
728
Change (1Y)
144
Growth (1Y)
24.66%
Revenue / Employee
$729,797
Profits / Employee
$98,437
Market Cap
3.80B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 728 | 144 | 24.66% |
| Dec 31, 2023 | 584 | 372 | 175.47% |
| Dec 31, 2022 | 212 | 64 | 43.24% |
| Dec 31, 2021 | 148 | 38 | 34.55% |
| Dec 31, 2020 | 110 | 1 | 0.92% |
| Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TMDX News
- 8 days ago - TransMedics to Present at Upcoming September Investor Conferences - PRNewsWire
- 8 days ago - TransMedics: CEO Is Buying Shares Ahead Of A Potentially Concerning Q3 - Seeking Alpha
- 4 weeks ago - TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial - PRNewsWire
- 4 weeks ago - TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 4 weeks ago - TransMedics: Continued Strength Suggests Further Upside - Seeking Alpha
- 4 weeks ago - TransMedics Group, Inc. (TMDX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - TransMedics Reports Second Quarter 2025 Financial Results - PRNewsWire
- 5 weeks ago - TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference - PRNewsWire